Home › Funds › Sio Capital Management, LLC › HAE

Sio Capital Management, LLC position in HAE

HAEMONETICS CORP MASS · Health Care

Sio Capital Management, LLC reported holding 44,700 shares of HAE (HAEMONETICS CORP MASS) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 0.93% of its reported portfolio and ranking #34 among its reported holdings. Sio Capital Management, LLC has disclosed HAE holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)44.70K sh
Reported value held$4.71M
Portfolio Weight0.93%
First reportedQ1 2025
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Sio Capital Management, LLC's HAE position evolved

Sio Capital Management, LLC first disclosed a stake in HAE in Q1 2025 at 133,966 shares (US$8.5M). The position peaked in Q1 2026 at 220,672 shares, worth US$12.4M. Across 5 filings, Sio Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 44,700 shares valued at US$4.7M. Notable position changes include a 53% trim in Q4 2025 (shares fell 30% over the following quarter), a 138% increase in Q1 2026 (shares rose 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 133.97K $8.51M New
Q3 2025 198.03K $9.65M New
Q4 2025 92.63K $7.42M Reduce
Q1 2026 220.67K $12.44M Add
Q3 2026 44.70K $4.71M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HAE and 13F data

HAE (HAEMONETICS CORP MASS) is a Health Care company. 25 other funds we track also report a position in HAE — the largest reported positions include ARIEL INVESTMENTS, LLC (US$228.9M), River Road Asset Management, LLC (US$110.1M), ExodusPoint Capital Management, LP (US$59.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HAE

All HAE fund holders →

FAQ

How long has Sio Capital Management, LLC held HAE?

Sio Capital Management, LLC has disclosed HAE holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

What is Sio Capital Management, LLC's current position in HAE?

As of Q3 2026, Sio Capital Management, LLC holds 44.70K shares of HAE (HAEMONETICS CORP MASS), valued at $4.71M, representing 0.93% of its reported portfolio and ranking #34.

Has Sio Capital Management, LLC been buying or selling HAE?

In the latest 13F filing (Q3 2026), Sio Capital Management, LLC newly opened its position in HAE. The position peaked in Q1 2026 at 220.67K shares.

Which other funds hold HAE?

Other major institutional holders of HAE include ARIEL INVESTMENTS, LLC, River Road Asset Management, LLC, ExodusPoint Capital Management, LP, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.